Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Langerhans Cell Histiocytosis Clinical Trials

2 recruiting trials for Langerhans Cell Histiocytosis. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
2
Total Trials
2
Recruiting Now
1
Phase 3 Trials
2
Sponsors

Recruiting Trials

RECRUITINGPhase 3NCT02670707

Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)

Langerhans Cell Histiocytosis (LCH) is a type of cancer that can damage tissue or cause lesions to form in one or more places in the body. Langerhans cell histiocytosis (LCH) is a...

Sponsor: Baylor College of MedicineEnrolling: 12411 locations
RECRUITINGPhase 2NCT06582745

Targeted Approach to Langerhans Cell Histiocytosis (LCH) Using MEK Inhibitor, Trametinib

The purpose of this Phase II clinical trial is to establish the safety and effectiveness of trametinib, a targeted therapy, for the treatment of newly or recently diagnosed...

Sponsor: Cook Children's Health Care SystemEnrolling: 751 location